Exscientia: GTAEXS617 (CDK7 Inhibitor) Initial Phase I Data Expected in 2H24 >EXAI
Exscientia: GTAEXS617 (CDK7 Inhibitor) Initial Phase I Data Expected in 2H24 >EXAI
Exscientia:GTAEXS617(CDK7 抑制劑)的初始I期數據預計將在24年下半年出爐 >EXAI
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊